このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Humana マネジメント

マネジメント基準チェック /24

Humana'sの CEO はJim Rechtinで、 Jan2024年に任命され、の在任期間は 1 年未満です。は、会社の株式の0%を直接所有しており、その価値は$ 4.22K 。経営陣と取締役会の平均在任期間はそれぞれ2年と3.9年です。

主要情報

Jim Rechtin

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	less than a year
CEOの所有権	0.00001%
経営陣の平均在職期間	2.1yrs
取締役会の平均在任期間	4yrs

経営陣の近況

Recent updates

CEO（最高経営責任者

Jim Rechtin (53 yo)

less than a year

在職期間

Mr. James A. Rechtin, also known as Jim, MBA, served as COO of Humana Inc. since January 08, 2024 until July 01, 2024 and serves as its President since January 08, 2024 and also serves as its Chief Executi...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Susan Diamond	Chief Financial Officer	3.3yrs	US$4.73m	0.0072% $ 2.7m
Joseph Ventura	Chief Legal Officer	5.6yrs	US$3.10m	0.0060% $ 2.3m
Bruce Broussard	Strategic Advisor	less than a year	US$16.33m	0.073% $ 27.7m
George Renaudin	President of Medicare & Medicaid	1.6yrs	US$3.11m	0.0032% $ 1.2m
Sanjay Shetty	President of CenterWell	1.5yrs	US$4.58m	0.00014% $ 52.8k
James Rechtin	President	less than a year	データなし	0.000010% $ 3.8k
John-Paul Felter	Senior VP	2.1yrs	データなし	0.00031% $ 116.8k
Eric Tagliere	Senior VP & CTO	less than a year	データなし	データなし
Samir Deshpande	Chief Information Officer	3.7yrs	データなし	0.010% $ 3.9m
Timothy Huval	Chief Administrative Officer	5.2yrs	US$3.73m	0.0061% $ 2.3m
Lisa Stoner	Vice President of Investor Relations	no data	データなし	データなし
Vishal Agrawal	Chief Strategy & Corporate Development Officer	5.8yrs	データなし	0.0090% $ 3.4m

2.1yrs

平均在職期間

51.5yo

平均年齢

経験豊富な経営陣: HUMの経営陣は経験豊富であると考えられます ( 2年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
James Rechtin	President	less than a year	データなし	0.000010% $ 3.8k
Kurt Hilzinger	Independent Chairman of the Board	21.2yrs	US$601.30k	0.016% $ 6.1m
Karen Katz	Independent Director	5yrs	US$346.55k	0.00049% $ 184.7k
Frank D'Amelio	Independent Director	21yrs	US$363.55k	0.017% $ 6.5m
Jorge Mesquita	Independent Director	3.6yrs	US$351.59k	0.0018% $ 670.9k
Brad Smith	Independent Director	2yrs	US$311.07k	0.00032% $ 120.6k
Wayne Frederick	Independent Director	4.6yrs	US$364.87k	0.00037% $ 139.5k
David Feinberg	Independent Director	2.5yrs	US$321.52k	0.00037% $ 139.5k
Marcy Klevorn	Independent Director	3.6yrs	US$351.94k	0.00036% $ 135.7k
John Garratt	Independent Director	4.6yrs	US$326.03k	0.0010% $ 392.0k
RaQuel Bono	Independent Director	4yrs	US$345.03k	0.00033% $ 124.4k

4.0yrs

平均在職期間

62yo

平均年齢

経験豊富なボード: HUMの取締役会は経験豊富であると考えられます ( 3.9年の平均在任期間)。

Humana マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

President exercised options and sold US$1.3m worth of stock

Humana Inc. Announces Management Changes

Chief Financial Officer recently sold US$415k worth of stock

Chief Financial Officer notifies of intention to sell stock

Recent updates

Upcoming dividend of US$0.89 per share

Humana's Falling Share Price Gives Investors An Opportunity

Humana (NYSE:HUM) Seems To Use Debt Quite Sensibly

Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Second quarter dividend of US$0.89 announced

Humana Settles for $90 Million Groundbreaking False Claims Act Case Alleging Medicare Part D Prescription Drug Program Fraud

Humana Inc. Declares Cash Dividend, Payable on October 25, 2024

Second quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2024

Humana: Outlook Improving Ahead Of Q2 Earnings, 'Buy' Thesis Intact

Investors Interested In Humana Inc.'s (NYSE:HUM) Earnings

Humana Inc. to Report Q2, 2024 Results on Jul 31, 2024

Humana: Medicare Advantage Will Never Be As Profitable As It Was

Humana (NYSE:HUM) Is Due To Pay A Dividend Of $0.885

Humana (NYSE:HUM) Will Pay A Dividend Of $0.885

Gainey Mckenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Humana, Inc

Humana Is Set Up For Long-Term Success

Humana (NYSE:HUM) Has Affirmed Its Dividend Of $0.885

First quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2024

Humana (NYSE:HUM) Is Paying Out A Dividend Of $0.885

Dividend of US$0.89 announced

Here's Why Humana (NYSE:HUM) Can Manage Its Debt Responsibly

Humana Inc. Declares Cash Dividend, Payable on July 26, 2024

Humana Inc. to Report Q1, 2024 Results on Apr 24, 2024

Humana: Where To Buy This

Humana: This Year's Drop Might Have Created A Buying Opportunity

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc. Declares Cash Dividend, Payable on April 26, 2024

Humana: A Golden Buying Opportunity As Fears Potentially Peaked

Humana Inc. Provides Earnings Guidance for 2024

Humana: The $300 Level Could Get Taken Out In The Near Future

Humana Announces Limited Layoffs

Humana: My Oh My, Another Strong Buy

Humana: Buy This Powerful Dividend Growth Stock In The New Year

Upcoming dividend of US$0.89 per share at 0.8% yield

President exercised options and sold US$1.3m worth of stock

Does Humana (NYSE:HUM) Have A Healthy Balance Sheet?

Humana: Failed Merger And Other Reasons To Buy

Cigna Reportedly Ends Humana Merger Talks

Cigna, Humana Reportedly in Talks for Merger

Humana Inc. Declares Cash Dividend, Payable on January 26, 2024

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana Inc. Announces Management Changes

Humana Inc. to Report Q3, 2023 Results on Nov 01, 2023

Humana: Upgrade To Buy

Humana Inc. (NYSE:HUM) agreed to acquire Senior-focused primary care centers in Texas and Nevada of Cano Health, LLC for $66.7 million.

Humana: Buy This Amazing Wealth Compounder Now, You'll Be Glad You Did

Upcoming dividend of US$0.89 per share at 0.7% yield

Centerwell Senior Primary Care Introduces In-Home Primary Care

We Think Humana (NYSE:HUM) Can Manage Its Debt With Ease

Humana Inc. Declares Cash Dividend, Payable on October 27, 2023

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2023

Humana: Mr. Market Got This One Right

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Humana: Recent Selloff Might Present A Buying Opportunity

Humana Inc. to Report Q2, 2023 Results on Aug 02, 2023

Humana: Rising Medical Costs Should Be Temporary

Upcoming dividend of US$0.89 per share at 0.8% yield

Humana: Margin Expansion Supported By Growing Memberships

Humana (NYSE:HUM) Seems To Use Debt Rather Sparingly

Chief Financial Officer recently sold US$415k worth of stock

Chief Financial Officer notifies of intention to sell stock

First quarter 2023 earnings: Revenues exceed analyst expectations

Humana Inc. (NYSE:HUM) Shares Could Be 49% Below Their Intrinsic Value Estimate

Upcoming dividend of US$0.89 per share at 0.7% yield

High number of new directors

President notifies of intention to sell stock

マネジメント基準チェック /24